Agape ATP
Wellness distributor with complementary therapies and renewable-energy services.
Something off on this page? Send us feedback.
Profile
Sells Malaysian wellness products and complementary therapies through a direct-selling network, while adding contract-based renewable-energy services for commercial, industrial and government customers; products are sourced and rebranded rather than manufactured.
Sells ATP Zeta and E.A.T.S. nutritional offerings through Agape Superior Living's member, distributor and stockist network, while DSY Wellness pairs screening reports with complementary therapies and products. Cedar ATPC adds skin-care and health-care products and customer training. Operations are concentrated in Malaysia, and health products are sourced, rebranded and distributed rather than manufactured.
Adds ATPC Green Energy, which provides solar generation and storage, energy-management systems, energy-efficiency work, installation, maintenance and sustainability consulting to commercial, industrial and government customers. Wellness revenue dominates the operating mix, while green-energy work is contract-based. The direct-selling model depends on independent members, distributors and stockists, while health products require Malaysian approvals and rely on third-party supplier quality and delivery.
Company facts
Key statistics
Year to date −53.9% · Average volume (30d) 263.0K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026Q2 FY26 | — | $0.09 | — | — | $13.7K | — | −0.40% |
| May 15, 2026Q1 FY26 | — | −$0.33 | — | — | $399.1K | — | −5.88% |
| Mar 30, 2026Q4 FY25 | — | $10.00 | — | — | $273.7K | — | −19.57% |
| Nov 13, 2025Q3 FY25 | — | −$0.01 | — | — | $370.6K | — | −2.90% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $289.0K | $465.5K | $370.6K | $399.1K | $273.7K | $13.7K | |
| Gross profit | $156.3K | $208.9K | $239.1K | $213.8K | $157.9K | $11.8K | |
| Operating income | −$720.4K | −$637.0K | −$601.3K | −$1.3M | −$677.4K | −$551.0K | |
| Net income | −$698.9K | −$617.1K | −$586.8K | −$376.9K | −$327.6K | $153.0K | |
| Diluted EPS | −$9.00 | −$0.62 | −$0.59 | −$0.38 | −$0.33 | $0.15 | |
| Gross margin | 54.1% | 44.9% | 64.5% | 53.6% | 57.7% | 86.0% | |
| Operating margin | -249.2% | -136.8% | -162.3% | -325.2% | -247.5% | -4,023.8% |
Fiscal years (4-quarter sums)FY21 $1.0M · FY22 $1.9M · FY23 $1.4M · FY24 $1.3M · FY25 $1.5M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $45.5K · Total debt $62.7K · Total assets $25.0M · Shareholders' equity $22.1M
Dividends
No dividends on record.
Ownership
Shares outstanding 1.00M · Float 433.3K · 43.3% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Jane Street Group, LLC | 50.2K | 5.00% | 13G | Jul 15, 2026 |
| UBS Group AG | 2.6K | 0.26% | 13F | May 5, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Herbalife
Nutrition and personal care sold through Malaysian distributor networks.
- USANA Health Sciences
Direct-selling nutrition and skin care challenger across Asia Pacific.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Agape ATP | $2.34 | −3.31% | $2.4M | — | — | 2.3 | −97.1% |
| Herbalife | $12.50 | +0.52% | $1.29B | 8.0 | 4.7 | 0.2 | +5.4% |
| USANA Health Sciences | $14.04 | +0.07% | $259.2M | — | 13.8 | 0.3 | −5.3% |
| Median | 8.0 | 9.2 | 0.3 | +0.0% |